Document Detail


Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.
MedLine Citation:
PMID:  20377768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: Long-term peritoneal dialysis (PD) may lead to peritoneal fibrosis and ultrafiltration failure. It had been demonstrated that the renin-angiotensin system (RAS) plays a key role in the regulation of peritoneal function in rats on PD. We investigated the effects of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) on long-term PD patients. METHODS: We analyzed data from 66 patients treated with PD therapy at our centre for at least 12 months retrospectively, during which time at least two peritoneal equilibration tests (PET) were performed. Thirty-eight patients were treated with ACE/angiotensin II (AII) inhibitors (ACE/ARB group); the other 28 received none of the above drugs during the entire follow up (control group). The expression of fibronectin, transforming growth factor-beta1 (TGF-beta1), Aquaporin1 (AQP1) and vascular endothelial growth factor (VEGF) in the overnight effluent were examined by enzyme-linked immunosorbent assay. RESULTS: The demographic data of the two groups showed no difference during the study. No difference between the groups was found with respect to residual renal function (RRF) at the start for both groups by the end of follow up, decreased in the vast majority of patients from both groups (P = 0.014). After 12 months, a significant difference in ultrafiltration was found between the two groups: in the control group it had decreased, while it had not changed in the ACE/ARB group (P < 0.05). In comparison with the baseline level, expression of fibronectin, TGF-beta1 and VEGF in dialysate effluent were significantly increased except for AQP1 in the control group (P < 0.05), but not in the ACE/ARB group (P > 0.05). CONCLUSION: The findings suggest that ACE/AII inhibitors appeared to have a slower rate of decline in ultrafiltration and RRF, effectively protect against peritoneal fibrosis in long-term peritoneal dialysis. Long-term follow up seems to be required to draw more conclusions.
Authors:
Sun Jing; Yu Kezhou; Zhang Hong; Wang Qun; Wang Rong
Related Documents :
6824428 - Prognosis in generalized peritonitis. relation to cause and risk factors.
18923748 - Relationship between inflammatory cytokines and cardiorenal anemia syndrome: treatment ...
3304198 - The treatment of generalized peritonitis by closed postoperative peritoneal lavage. a c...
9150708 - Perioperative use of recombinant human erythropoietin in patients refusing blood transf...
23826008 - Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remit...
20887128 - Craniometric changes in patients with acromegaly from a surgical perspective.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephrology (Carlton, Vic.)     Volume:  15     ISSN:  1440-1797     ISO Abbreviation:  Nephrology (Carlton)     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-04-09     Completed Date:  2010-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9615568     Medline TA:  Nephrology (Carlton)     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  27-32     Citation Subset:  IM    
Affiliation:
Department of Kidney, Shandong Provincial Hospital, Shandong University, Jinan, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Female
Humans
Kidney Failure, Chronic / therapy
Male
Middle Aged
Peritoneal Dialysis / adverse effects*
Peritoneal Fibrosis / etiology*,  prevention & control*
Retrospective Studies
Young Adult
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients.
Next Document:  Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodia...